麻豆传媒

Nephrology >

Type 1 Diabetes

News, opinions and meeting coverage in nephrology.

EndoBreak: After Menopause, Take the Stairs; Don't Try Kratom For T2D

News and commentary from the endocrinology world

Should More EMS Responders Be Allowed to Give Glucagon?

Researchers argue the agent is underused to treat severe hypoglycemia

What's Behind the Link Between Type 1 Diabetes and Celiac Disease?

Real culprit may not lie in our genes, but in our environment

EndoBreak: Novo Settles Whistleblower Lawsuit; Hyperkalemia Tx Warning

News and commentary from the endocrinology world

Nasal Glucagon Helps Hypoglycemia in Adults with T1D

Possible alternative to injectable recombinant glucagon

Committee Wants Diabetes Docs to Watch Their Language

Not the word police, but 'diabetic' and 'non-compliant' must go

ADA Policy on Photos, Videos, Twitter Sparks Controversy

Association asked meeting-goers to delete tweets of presentation slides

Metformin No Help for Atherosclerosis in T1D

Findings don't support metformin in long-standing type 1 diabetes

Morning Break: Tainted Trials; $40K/Yr Concierge Practice; Reality TV: Diabetes

Health news and commentary from around the Web gathered by the 麻豆传媒 staff

Early Prevention, Treatment Key in Diabetic Kidney Disease

Experts say technology basis for patient care and prevention

Post-Bariatric Hypoglycemia Prevented Through Novel Glucagon Pump

In small study, novel system used CGM with investigational liquid treatment

Longer-Term Home Use Safe for Artificial Pancreas System

3-month study might pave way to FDA clearance

Is 2018 the Year of the Bionic Pancreas?

Two experts review the state of closed-loop systems for type 1 diabetes

Biosimilar Insulin Glargine Matches Up With Lantus in Phase III

Merck's copycat has similar HbA1c effect in trial

More Promising Results for Bionic Pancreas

But studies are short-term and relatively small

What's New in Beta Cell Transplantation

Gene editing, stem cells raise new possibilities

Automated Glucagon System Linked to Reduced Hypoglycemia

System acted as an effective counterbalance to slower insulin intake

Opinion Makers: What's the Deal With Blinded CGM Readings?

Steven Edelman, MD, on letting patients see their glucose numbers

Why Did Afrezza Flop?

Patients don't hate needles that much, docs suggest

Judge: Medicare Must Cover CGM for T1D Patient

Courts may be forcing CMS' hand for coverage of continuous glucose monitors

Novo Nordisk Gives Up on Victoza in T1D

Lackluster results for liraglutide as adjunct to insulin therapy

T1D Patients Face Nearly Double Risk for Dementia

Findings still significant after controlling for vascular risk factors.

Diabetic Seniors Lobby for Medicare to Cover CGM Devices

Senate panel highlights glucose control issues facing Medicare patients with diabetes.

ADA: Glucagon Nasal Powder Effective for Kids

Device that shoots powder up nose safe and effective, finds study.

Three Diabetes Drugs Linked to Ketoacidosis, FDA Warns

FDA targets SGLT2 inhibitors canagliflozin, dapagliflozin, and empagliflozin.

Slippery Slope: Diet Drugs No Help for Heart

In another edition of the Slippery Slope series examining use of surrogate endpoints in drug approvals, 麻豆传媒 and the Milwaukee Journal Sentinel find diet drugs are approved without solid evidence of benefits, but with hints of harm.

Endo Apps: The DIY Artificial Pancreas

Type 1 diabetics and their parents find solutions for closed-loop control.

Morning Break: Penis Reduction? Patient Suffering

Health news and commentary from around the Web, gathered by the 麻豆传媒 staff.

New Treatments for High Potassium on the Horizon

But ultimate success is far from guaranteed.

Review: Telcare Glucose Meter

An easy-to-use glucose monitor uploads data to the cloud for ready access.